Literature DB >> 10741272

Tamoxifen for the prevention of breast cancer.

B Fisher1, T J Powles, K J Pritchard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10741272     DOI： 10.1016/s0959-8049(99)00269-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  Monitoring clinical trials. Dissemination of decisions on interim analyses needs wider debate.

Authors:  S M Bird
Journal:  BMJ       Date:  2001-12-15

Review 2.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

3.  IGF status is altered by tamoxifen in patients with breast cancer.

Authors:  M J Campbell; J V Woodside; J Secker-Walker; A Titcomb; A J Leathem
Journal:  Mol Pathol       Date:  2001-10

Review 4.  Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer.

Authors:  Etienne Leygue
Journal:  Nucl Recept Signal       Date:  2007-08-03

Review 5.  A vision for the future?

Authors:  M Baum
Journal:  Br J Cancer       Date:  2001-11       Impact factor: 7.640

6.  Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene.

Authors:  Benedito B da Silva; Daniel S Moita; Cleicilene G Pires; Edílson C Sousa-Junior; Alesse R dos Santos; Pedro V Lopes-Costa
Journal:  Int Semin Surg Oncol       Date:  2007-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.